Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1998-11-13
1999-11-09
Davis, Zinna Norhtington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514307, 540576, 546149, C07D21704, A61K 3147
Patent
active
059815213
ABSTRACT:
Tetrahydroisoquinoline derivatives of the formula: ##STR1## or a pharmaceutically acceptable salt, ester, or prodrug thereof, having activity as an LHRH antagonist, as well as pharmaceutical compositions containing the same, and methods for their use and preparation.
REFERENCES:
patent: 5110904 (1992-05-01), Haviv et al.
patent: 5140009 (1992-08-01), Haviv et al.
patent: 5502035 (1996-03-01), Haviv et al.
Science, vol. 202, (OCt. 1978), Andrew V. Schally, pp. 18-28, "Aspects of Hypothalamic Regulation of the Pituitary Gland".
Bruncko Milan
Crawford Bradley W.
DeMattei John
Dwight Wesley J.
Frey Lisa M.
Abbott Laboratories
Chen Portia
Davis Zinna Norhtington
LandOfFree
Tetrahydroisoquinoline derivatives as LHRH antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydroisoquinoline derivatives as LHRH antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroisoquinoline derivatives as LHRH antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456169